Yohann Dabi, Amélia Favier, Léo Razakamanantsoa, Léa Delbos, Mathieu Poilblanc, Philippe Descamps, Francois Golfier, Cyril Touboul, Sofiane Bendifallah, Emile Daraï
Ovarian tumors are the most frequent adnexal mass, raising diagnostic and therapeutic issues linked to a large spectrum of tumors, with a continuum from benign to malignant. Thus far, none of the available diagnostic tools have proven efficient in deciding strategy, and no consensus exists on the best strategy between "single test", "dual testing", "sequential testing", "multiple testing options" and "no testing". In addition, there is a need for prognostic tools such as biological markers of recurrence and theragnostic tools to detect women not responding to chemotherapy in order to adapt therapies...
February 28, 2023: Cancers